National Institutes of Health’s National Center for Advancing Translational Sciences

Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines will soon be lining up for another dose.  On Oct. 20, the U.S. Food and Drug Administration authorized a third dose of Moderna’s mRNA vaccine for select groups. The groups include people age 65 and older as well as 18- to 64-year-olds who […]